Combining Short- and Long-Read Sequencing Technologies to Identify SARS-CoV-2 Variants in Wastewater.

Combining Short- and Long-Read Sequencing Technologies to Identify SARS-CoV-2 Variants in Wastewater.

Publication date: Sep 21, 2024

During the COVID-19 pandemic, the monitoring of SARS-CoV-2 RNA in wastewater was used to track the evolution and emergence of variant lineages and gauge infection levels in the community, informing appropriate public health responses without relying solely on clinical testing. As more sublineages were discovered, it increased the difficulty in identifying distinct variants in a mixed population sample, particularly those without a known lineage. Here, we compare the sequencing technology from Illumina and from Oxford Nanopore Technologies, in order to determine their efficacy at detecting variants of differing abundance, using 248 wastewater samples from various Quebec and Ontario cities. Our study used two analytical approaches to identify the main variants in the samples: the presence of signature and marker mutations and the co-occurrence of signature mutations within the same amplicon. We observed that each sequencing method detected certain variants at different frequencies as each method preferentially detects mutations of distinct variants. Illumina sequencing detected more mutations with a predominant lineage that is in low abundance across the population or unknown for that time period, while Nanopore sequencing had a higher detection rate of mutations that are predominantly found in the high abundance B. 1.1. 7 (Alpha) lineage as well as a higher sequencing rate of co-occurring mutations in the same amplicon. We present a workflow that integrates short-read and long-read sequencing to improve the detection of SARS-CoV-2 variant lineages in mixed population samples, such as wastewater.

Open Access PDF

Concepts Keywords
Abundance coronaviruses
Nanopore COVID-19
Oxford Genome, Viral
Pandemic High-Throughput Nucleotide Sequencing
Wastewater Humans
Illumina sequencing
Mutation
Nanopore Sequencing
Nanopore sequencing
Ontario
Quebec
RNA, Viral
RNA, Viral
SARS-CoV-2
SARS-CoV-2
variants
Wastewater
Wastewater
wastewater surveillance

Semantics

Type Source Name
disease MESH COVID-19 pandemic
disease MESH infection
drug DRUGBANK Diethylstilbestrol
drug DRUGBANK Coenzyme M
disease IDO virulence
drug DRUGBANK Ademetionine
disease MESH viral load
disease IDO contact tracing
disease IDO quality
drug DRUGBANK Polyethylene glycol
drug DRUGBANK Phenol
disease IDO reagent
drug DRUGBANK Water
drug DRUGBANK Microcrystalline cellulose
drug DRUGBANK Methylergometrine
disease MESH Mutation Frequency
drug DRUGBANK Aspartame
drug DRUGBANK Nonoxynol-9
drug DRUGBANK Tropicamide
drug DRUGBANK Sulpiride
disease IDO cell

Original Article

(Visited 3 times, 1 visits today)